Biodexa Pharmaceuticals BDRX Growth Metrics (2014-2024)

NASDAQ BDRX
$0.81 -0.02 (-2.24%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Biodexa Pharmaceuticals Quarterly Growth Metrics

Periods 13 quarters
Latest Dec 2024

Biodexa Pharmaceuticals growth metrics data for the quarter ended Dec 2024. These growth metrics cover 13 quarters of results from Dec 2014 through Dec 2024, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Sep2021 Dec2021 Sep2022 Dec2022 Dec2023 Dec2024
Growth Ratios
EBITDA Margin Growth (1y) 0.02M0.01M-0.02M-0.22M-1.12M
EBITDA Margin Growth (3y) 0.01M-0.23M-1.36M
EBITDA Margin Growth (5y) -1.33M
EBIT Margin Growth (1y) 0.02M0.01M-0.02M-0.22M-1.12M
EBIT Margin Growth (3y) 0.01M-0.23M-1.36M
EBIT Margin Growth (5y) -1.33M
EBT Margin Growth (1y) 0.02M0.01M-0.02M-0.21M-1.16M
EBT Margin Growth (3y) 0.01M-0.22M-1.39M
EBT Margin Growth (5y) -1.35M
FCF Margin Growth (1y) 0.02M-0.00M-0.02M0.01M0.00M
FCF Margin Growth (3y) 0.00M-0.00M0.00M
FCF Margin Growth (5y) 0.02M
Gross Margin Growth (1y) -0.01M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) 414.88%596.36%516.63%-95.48%-82.76%479.70%-54.19%-97.51%-16.08%659.34%275.68%15.98%-55.91%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) 504.68%24.72%-63.65%-64.39%-22.92%30.62%13.04%54.06%24.32%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y) 11.49%14.16%-33.75%-55.54%7.62%57.56%-5.88%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) 116.39%
Net Margin Growth (1y) 0.01M0.00M-0.02M-0.18M-1.09M
Net Margin Growth (3y) -0.01M-0.21M-1.30M
Net Margin Growth (5y) -1.29M
Operating Margin Growth (1y) 0.02M0.01M-0.02M-0.22M-1.12M
Operating Margin Growth (3y) 0.01M-0.23M-1.36M
Operating Margin Growth (5y) -1.33M
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -0.00M-0.01M0.01M0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y) -0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y) 0.01M0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) -0.00M-0.01M0.01M0.04M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y) -0.00M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y) -0.04M-0.01M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) 0.02M0.01M-0.02M-0.22M-1.12M
Return on Sales [ROS] Growth (3y)ROS Growth (3y) 0.01M-0.23M-1.36M
Return on Sales [ROS] Growth (5y)ROS Growth (5y) -1.33M